Stay updated on Pembrolizumab CNS Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page
- Check2 days agoChange DetectedThis update adds posted results and expands the description of primary and secondary outcomes, including intracranial and extracranial endpoints and toxicity measures, with definitions and time frames. It also adds study documents (protocol and informed consent) and notes the results submission/posting dates, reflecting new data availability and end-point details.SummaryDifference3%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the recruitment status updated to No longer looking for participants, clarifying how to engage with the study. A formatting adjustment to the Intervention/Treatment header accompanies a version update (Revision: v3.6.0) with the older revision tag removed.SummaryDifference0.4%

- Check23 days agoChange DetectedThe page now shows a Revision: v3.5.5 tag, replacing the previous v3.5.4 tag, indicating the current software version powering the site.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.5.4 replaces the previous v3.5.3 on the study page. This represents a minor site build update to the rendering template used for the record, with no change to the study data.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check73 days agoChange DetectedSystem revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.